MY121135A - Derivatives of monosaccharides as cell adhesion inhibitors. - Google Patents

Derivatives of monosaccharides as cell adhesion inhibitors.

Info

Publication number
MY121135A
MY121135A MYPI20000121A MYPI20000121A MY121135A MY 121135 A MY121135 A MY 121135A MY PI20000121 A MYPI20000121 A MY PI20000121A MY PI20000121 A MYPI20000121 A MY PI20000121A MY 121135 A MY121135 A MY 121135A
Authority
MY
Malaysia
Prior art keywords
cell adhesion
derivatives
monosaccharides
xylo
isopropylidene
Prior art date
Application number
MYPI20000121A
Other languages
English (en)
Inventor
Sudershan K Arora
Nawal Kishore
Jang B Gupta
Vishwas D Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MY121135A publication Critical patent/MY121135A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MYPI20000121A 1999-01-15 2000-01-14 Derivatives of monosaccharides as cell adhesion inhibitors. MY121135A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
MY121135A true MY121135A (en) 2005-12-30

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20000121A MY121135A (en) 1999-01-15 2000-01-14 Derivatives of monosaccharides as cell adhesion inhibitors.

Country Status (30)

Country Link
US (5) US6590085B1 (enExample)
EP (1) EP1147119B1 (enExample)
JP (1) JP2002534530A (enExample)
CN (1) CN1167707C (enExample)
AR (1) AR022235A1 (enExample)
AT (1) ATE250074T1 (enExample)
AU (1) AU768511B2 (enExample)
BG (1) BG105745A (enExample)
BR (1) BR0007553A (enExample)
CA (1) CA2359986A1 (enExample)
CO (1) CO5180591A1 (enExample)
CR (1) CR6423A (enExample)
CZ (1) CZ20012540A3 (enExample)
DE (1) DE60005300T2 (enExample)
DK (1) DK1147119T3 (enExample)
ES (1) ES2206176T3 (enExample)
HR (1) HRP20010529B1 (enExample)
HU (1) HUP0105116A3 (enExample)
ID (1) ID30351A (enExample)
IN (1) IN190975B (enExample)
MA (1) MA25342A1 (enExample)
MX (1) MXPA01007187A (enExample)
MY (1) MY121135A (enExample)
NZ (2) NZ512852A (enExample)
PA (1) PA8489901A1 (enExample)
PT (1) PT1147119E (enExample)
SK (1) SK284241B6 (enExample)
TR (1) TR200102043T2 (enExample)
WO (1) WO2000042054A1 (enExample)
YU (1) YU50701A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
SG141430A1 (en) 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
EP1789428A1 (en) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
AU768511B2 (en) 2003-12-18
US6590085B1 (en) 2003-07-08
HK1041270A1 (en) 2002-07-05
ID30351A (id) 2001-11-22
NZ512852A (en) 2004-02-27
TR200102043T2 (tr) 2001-11-21
US20040023900A1 (en) 2004-02-05
HRP20010529B1 (en) 2005-02-28
CO5180591A1 (es) 2002-07-30
CN1343213A (zh) 2002-04-03
WO2000042054A1 (en) 2000-07-20
HUP0105116A2 (hu) 2003-04-28
US7037899B2 (en) 2006-05-02
JP2002534530A (ja) 2002-10-15
CR6423A (enExample) 2004-03-09
DE60005300D1 (de) 2003-10-23
YU50701A (sh) 2005-06-10
EP1147119A1 (en) 2001-10-24
BG105745A (en) 2002-05-31
US7005516B2 (en) 2006-02-28
MXPA01007187A (es) 2002-04-24
SK10132001A3 (sk) 2002-01-07
AU1886100A (en) 2000-08-01
ATE250074T1 (de) 2003-10-15
US7005422B2 (en) 2006-02-28
DK1147119T3 (da) 2004-01-19
ES2206176T3 (es) 2004-05-16
PA8489901A1 (es) 2000-09-29
HUP0105116A3 (en) 2003-05-28
CZ20012540A3 (cs) 2002-02-13
AR022235A1 (es) 2002-09-04
DE60005300T2 (de) 2004-07-15
PT1147119E (pt) 2004-02-27
NZ527483A (en) 2005-02-25
CN1167707C (zh) 2004-09-22
SK284241B6 (en) 2004-11-03
US20040019191A1 (en) 2004-01-29
CA2359986A1 (en) 2000-07-20
US20040018995A1 (en) 2004-01-29
HRP20010529A2 (en) 2002-08-31
BR0007553A (pt) 2001-12-18
MA25342A1 (fr) 2001-12-31
US20040029820A1 (en) 2004-02-12
EP1147119B1 (en) 2003-09-17
IN190975B (enExample) 2003-09-06

Similar Documents

Publication Publication Date Title
AU589686B2 (en) Intermediates for the production of amino and substituted amino phosphinylalkanoyl compositions
YU50701A (sh) 2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezije
WO2001014328A3 (en) Substituted ureas as cell adhesion inhibitors
WO2000055139A3 (en) Heterocyclic urea and related compounds useful as anti-inflammatory agents
SG158733A1 (en) Cell adhesion inhibitors
FI973087A7 (fi) Soluadheesion inhibiittoreita
WO2000008048A3 (en) Inhibitor of histone deacetylase
ES8705038A1 (es) Un procedimiento para preparar azatricicloalquenos.
NZ312950A (en) Cell adhesion inhibitors that inhibit the binding of ligands to VLA-4
IL141486A0 (en) Pharmaceutical compositions containing a cd2 binding agent
ATE314137T1 (de) Betainprodukt,verfahren zu seiner herstellung und seiner verwendung
ZA983704B (en) Phosphodiesterase 4-inhibiting diazepinoindolones.
WO2002056832A3 (en) Methods to treat autoimmune and inflammatory conditions
IL181267A0 (en) Vla-4 antagonists
ES8604223A1 (es) Un procedimiento para preparar derivados de purina
JO2237B1 (en) Derivatives of the mono glycemic compound are used as cellular adhesion inhibitors
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
WO2006016237A3 (en) Heterocyclic derivatives as anti-inflammatory agents
WO2003086325A3 (en) Cyanamides useful as reversible inhibitors of cysteine proteases
WO2003084941A3 (en) Hydroxamic acid derivatives
WO2000006575A3 (en) Azabicyclic compounds
Park et al. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A
PL345917A1 (en) Novel arylic and heteroarylic compounds of quinolinylphosphonic acid, method of obtaining them and pharmacological compositions containing such compounds
PL345916A1 (en) Novel compounds of 6-amino- or 6-hydrazin-sulphonyl-3-quinolinylphosphonic acid, method of obtaining them and pharmacological compositions containing such compounds